Literature DB >> 30165691

The association of calcium oxalate deposition in kidney allografts with graft and patient survival.

Ragnar Palsson1, Anil K Chandraker1, Gary C Curhan1, Helmut G Rennke2, Gearoid M McMahon1, Sushrut S Waikar1.   

Abstract

BACKGROUND: Whether calcium oxalate (CaOx) deposition in kidney allografts following transplantation (Tx) adversely affects patient outcomes is uncertain, as are its associated risk factors.
METHODS: We performed a retrospective cohort study of patients who had kidney allograft biopsies performed within 3 months of Tx at Brigham and Women's Hospital and examined the association of CaOx deposition with the composite outcome of death or graft failure within 5 years.
RESULTS: Biopsies from 67 of 346 patients (19.4%) had CaOx deposition. In a multivariable logistic regression model, higher serum creatinine [odds ratio (OR) = 1.28 per mg/dL, 95% confidence interval (CI) 1.15-1.43], longer time on dialysis (OR = 1.11 per additional year, 95% CI 1.01-1.23) and diabetes (OR = 2.26, 95% CI 1.09-4.66) were found to be independently associated with CaOx deposition. CaOx deposition was strongly associated with delayed graft function (DGF; OR = 11.31, 95% CI 5.97-21.40), and with increased hazard of the composite outcome after adjusting for black recipient race, donor type, time on dialysis before Tx, diabetes and borderline or acute rejection (hazard ratio 1.90, 95% CI 1.13-3.20).
CONCLUSIONS: CaOx deposition is common in allografts with poor function and portends worse outcomes up to 5 years after Tx. The extent to which CaOx deposition may contribute to versus result from DGF, however, cannot be determined based on our retrospective and observational data. Future studies should examine whether reducing plasma and urine oxalate prevents CaOx deposition in the newly transplanted kidney and whether this has an effect on clinical outcomes.
© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  biopsy; calcium oxalate; graft survival; kidney transplantation; renal insufficiency

Mesh:

Substances:

Year:  2020        PMID: 30165691      PMCID: PMC7849934          DOI: 10.1093/ndt/gfy271

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  36 in total

1.  Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: was mycophenolate the cause?

Authors:  Alireza Hamidian Jahromi; Hamidian Jahromi A; Ian S D Roberts; Chris G Winearls; Anil Vaidya
Journal:  Nephrol Dial Transplant       Date:  2008-04-09       Impact factor: 5.992

2.  Subclinical celiac disease and crystal-induced kidney disease following kidney transplant.

Authors:  Giovanna Capolongo; Sameh Abul-Ezz; Orson W Moe; Khashayar Sakhaee
Journal:  Am J Kidney Dis       Date:  2012-06-26       Impact factor: 8.860

3.  Recurrence of primary hyperoxaluria after kidney transplantation.

Authors:  Tahereh Malakoutian; Mojgan Asgari; Massoud Houshmand; Ronak Mohammadi; Omid Aryani; Esmaeel Mohammadi Pargoo; Ahad J Ghods
Journal:  Iran J Kidney Dis       Date:  2011-11       Impact factor: 0.892

Review 4.  Enteric hyperoxaluria: an important cause of end-stage kidney disease.

Authors:  Lama Nazzal; Sonika Puri; David S Goldfarb
Journal:  Nephrol Dial Transplant       Date:  2015-02-20       Impact factor: 5.992

5.  Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications.

Authors:  Luan D Truong; Ulkem Yakupoglu; Daniel Feig; John Hicks; Joiner Cartwight; David Sheikh-Hamad; Wadi N Suki
Journal:  Am J Transplant       Date:  2004-08       Impact factor: 8.086

6.  Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys.

Authors:  Marino Asselman; Anja Verhulst; Marc E De Broe; Carl F Verkoelen
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

7.  Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.

Authors:  Christopher Hartman; Justin I Friedlander; Daniel M Moreira; Sammy E Elsamra; Arthur D Smith; Zeph Okeke
Journal:  BJU Int       Date:  2014-08-13       Impact factor: 5.588

8.  Acute oxalate nephropathy following kidney transplantation: Report of three cases.

Authors:  Diana Taheri; Alaleh Gheissari; Pooria Shaabani; Seyed Reza Tabibian; Mojgan Mortazavi; Shiva Seirafian; Alireza Merrikhi; Mehdi Fesharakizadeh; Shahaboddin Dolatkhah
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

9.  Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria.

Authors:  Yanwei Cao; Wanpeng Liu; Limei Hui; Jianjun Zhao; Xuecheng Yang; Yonghua Wang; Haitao Niu
Journal:  Urolithiasis       Date:  2016-04-04       Impact factor: 3.436

10.  NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.

Authors:  Felix Knauf; John R Asplin; Ignacio Granja; Insa M Schmidt; Gilbert W Moeckel; Rachel J David; Richard A Flavell; Peter S Aronson
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

View more
  11 in total

1.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

2.  Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease.

Authors:  Laura I Neumeier; Robert B Thomson; Martin Reichel; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

3.  Assessment of Plasma Oxalate Concentration in Patients With CKD.

Authors:  Anja Pfau; Monika Wytopil; Kinsuk Chauhan; Martin Reichel; Steve G Coca; Peter S Aronson; Kai-Uwe Eckardt; Felix Knauf
Journal:  Kidney Int Rep       Date:  2020-09-02

4.  Oxalate deposition in renal allograft biopsies within 3 months after transplantation is associated with allograft dysfunction.

Authors:  Malou L H Snijders; Dennis A Hesselink; Marian C Clahsen-van Groningen; Joke I Roodnat
Journal:  PLoS One       Date:  2019-04-16       Impact factor: 3.240

Review 5.  Dietary Oxalate Intake and Kidney Outcomes.

Authors:  Matteo Bargagli; Maria Clarissa Tio; Sushrut S Waikar; Pietro Manuel Ferraro
Journal:  Nutrients       Date:  2020-09-02       Impact factor: 5.717

Review 6.  Two Faces of Vitamin C in Hemodialysis Patients: Relation to Oxidative Stress and Inflammation.

Authors:  Patrick Chaghouri; Nour Maalouf; Sophia Lorina Peters; Piotr Jan Nowak; Katarzyna Peczek; Anna Zasowska-Nowak; Michal Nowicki
Journal:  Nutrients       Date:  2021-02-27       Impact factor: 5.717

7.  Author Reply to Comment on "Assessment of Plasma Oxalate Concentration in Patients With CKD" by Oka et al.

Authors:  Anja Pfau; Monika Wytopil; Kinsuk Chauhan; Martin Reichel; Steve Coca; Peter S Aronson; Kai-Uwe Eckardt; Felix Knauf
Journal:  Kidney Int Rep       Date:  2021-03-05

8.  Detection and localization of calcium oxalate in kidney using synchrotron deep ultraviolet fluorescence microscopy.

Authors:  Emmanuel Estève; David Buob; Frédéric Jamme; Chantal Jouanneau; Slavka Kascakova; Jean Philippe Haymann; Emmanuel Letavernier; Louise Galmiche; Pierre Ronco; Michel Daudon; Dominique Bazin; Matthieu Réfrégiers
Journal:  J Synchrotron Radiat       Date:  2022-01-01       Impact factor: 2.616

9.  High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.

Authors:  Anja Pfau; Theresa Ermer; Steven G Coca; Maria Clarissa Tio; Bernd Genser; Martin Reichel; Fredric O Finkelstein; Winfried März; Christoph Wanner; Sushrut S Waikar; Kai-Uwe Eckardt; Peter S Aronson; Christiane Drechsler; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2021-07-19       Impact factor: 14.978

10.  Posttransplant recurrence of calcium oxalate crystals in patients with primary hyperoxaluria: Incidence, risk factors, and effect on renal allograft function.

Authors:  Lynn D Cornell; Hatem Amer; Jason K Viehman; Ramila A Mehta; John C Lieske; Elizabeth C Lorenz; Julie K Heimbach; Mark D Stegall; Dawn S Milliner
Journal:  Am J Transplant       Date:  2021-07-26       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.